Neurocrine Biosciences agreed to buy Soleno Therapeutics for $2.9 billion in a move intended to expand its endocrinology and rare-disease portfolio.
Source link
Neurocrine to Buy Soleno for $2.9 Billion
Date:
More like thisRelated
Ewing sarcoma cluster has California suburb looking for cause
A string of rare childhood cancer cases in this...
Riley Green Says He’s Not Trying to Be the Next Morgan Wallen
Riley Green gets a lot of outside songs sent...
Silver Lake Takes On Carl Icahn and the Merger Arbitrage World in Endeavor Fight
The private-equity firm is asking a judge to declare...